EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Glucocorticoid Receptor Regulates and Interacts with LEDGF/p75 to Promote Docetaxel Resistance in Prostate Cancer Cells

Evelyn S Sanchez-Hernandez, Pedro T Ochoa, Tise Suzuki iD, Greisha L Ortiz-Hernandez iD, Juli J Unternaehrer iD, Hossam R Alkashgari, Carlos J Diaz Osterman, Shannalee R Martinez, Zhong Chen, Isaac Kremsky, Charles Wang iD, Carlos A Casiano iD

Cells · 11.08.2023 · 12 (16) · 2046

DOI: 10.3390/cells12162046 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, online erschienen am 11.08.2023. Verfasst von Evelyn S Sanchez-Hernandez und 11 weiteren Autor:innen. Beteiligte Einrichtung: Center for Health Disparities and Molecular Medicine, Loma Linda University School of Medicine, Loma Linda, CA 92350, USA. Hauptthemen laut MEDLINE: Receptors, Glucocorticoid, Prostatic Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIMHD NIH HHS, NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patients with advanced prostate cancer (PCa) invariably develop resistance to anti-androgen therapy and taxane-based chemotherapy. Glucocorticoid receptor (GR) has been implicated in PCa therapy resistance; however, the mechanisms underlying GR-mediated chemoresistance remain unclear. Lens epithelium-derived growth factor p75 (LEDGF/p75, also known as PSIP1 and DFS70) is a glucocorticoid-induced transcription co-activator implicated in cancer chemoresistance. We investigated the contribution of the GR–LEDGF/p75 axis to docetaxel (DTX)-resistance in PCa cells. GR silencing in DTX-sensitive and -resistant PCa cells decreased LEDGF/p75 expression, and GR upregulation in enzalutamide-resistant cells correlated with increased LEDGF/p75 expression. ChIP-sequencing revealed GR binding sites in the LEDGF/p75 promoter. STRING protein–protein interaction analysis indicated that GR and LEDGF/p75 belong to the same transcriptional network, and immunochemical studies demonstrated their co-immunoprecipitation and co-localization in DTX-resistant cells. The GR modulators exicorilant and relacorilant increased the sensitivity of chemoresistant PCa cells to DTX-induced cell death, and this effect was more pronounced upon LEDGF/p75 silencing. RNA-sequencing of DTX-resistant cells with GR or LEDGF/p75 knockdown revealed a transcriptomic overlap targeting signaling pathways associated with cell survival and proliferation, cancer, and therapy resistance. These studies implicate the GR–LEDGF/p75 axis in PCa therapy resistance and provide a pre-clinical rationale for developing novel therapeutic strategies for advanced PCa.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, GlucocorticoidProstatic NeoplasmsMaleHumansDocetaxelIntercellular Signaling Peptides and ProteinsGlucocorticoids

Stichwörter der Autor:innen

LEDGF/p75autoantibodieschemoresistancedocetaxelexicorilantglucocorticoid receptorprostate cancerrelacorilant

Substanzen

Docetaxellens epithelium-derived growth factorReceptors, GlucocorticoidIntercellular Signaling Peptides and ProteinsGlucocorticoids

Autor:innen und Institutionen

  • Center for Health Disparities and Molecular Medicine, Loma Linda University School of Medicine, Loma Linda, CA 92350, USA.
  • Department of Basic Sciences, Loma Linda University School of Medicine, Loma Linda, CA 92350, USA.
  • Department of Physiology, College of Medicine, University of Jeddah, Jeddah 23890, Saudi Arabia.
  • Department of Basic Sciences, Ponce Health Sciences University, Ponce, PR 00716, USA.
  • Center for Genomics, Loma Linda University School of Medicine, Loma Linda, CA 92350, USA.
  • Rheumatology Division, Department of Medicine, Loma Linda University School of Medicine, Loma Linda, CA 92350, USA.

ORCID-Profile: Tise Suzuki, Greisha L Ortiz-Hernandez, Juli J Unternaehrer, Charles Wang, Carlos A Casiano

Förderung

  • NIMHD NIH HHS
  • NIH HHS
  • NIGMS NIH HHS
  • NCI NIH HHS
  • NIH
  • Loma Linda University Center for Health Disparities and Molecular Medicine
  • NSF

Zitieren

APA

Sanchez-Hernandez, E. S., Ochoa, P. T., Suzuki, T., Ortiz-Hernandez, G. L., Unternaehrer, J. J., Alkashgari, H. R., Diaz Osterman, C. J., Martinez, S. R., Chen, Z., Kremsky, I., Wang, C., & Casiano, C. A. (2023). Glucocorticoid Receptor Regulates and Interacts with LEDGF/p75 to Promote Docetaxel Resistance in Prostate Cancer Cells. Cells, 12(16), 2046. https://doi.org/10.3390/cells12162046

Vancouver

Sanchez-Hernandez ES, Ochoa PT, Suzuki T, Ortiz-Hernandez GL, Unternaehrer JJ, Alkashgari HR, et al. Glucocorticoid Receptor Regulates and Interacts with LEDGF/p75 to Promote Docetaxel Resistance in Prostate Cancer Cells. Cells. 2023;12(16):2046. doi:10.3390/cells12162046

BibTeX
@article{SanchezHernandez2023,
  author = {Sanchez-Hernandez, Evelyn S and Ochoa, Pedro T and Suzuki, Tise and Ortiz-Hernandez, Greisha L and Unternaehrer, Juli J and Alkashgari, Hossam R and Diaz Osterman, Carlos J and Martinez, Shannalee R and Chen, Zhong and Kremsky, Isaac and Wang, Charles and Casiano, Carlos A},
  title = {Glucocorticoid Receptor Regulates and Interacts with LEDGF/p75 to Promote Docetaxel Resistance in Prostate Cancer Cells},
  journal = {Cells},
  year = {2023},
  volume = {12},
  number = {16},
  pages = {2046},
  doi = {10.3390/cells12162046}
}
Kostenlos starten →